Sign in

CIK 0001907108

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Lexeo Therapeutics, Inc.

Sign in to watch
Ticker
LXEO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
854012572
Phone
+1 212-547-9879
Business address
345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$18,214
in 3 filings

Net −$18,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-11-07 Omega Fund VI, L.P. 10% owner Conversion +1,415,865 1,415,865
2023-11-07 Omega Fund VI, L.P. 10% owner Conversion +287,213 1,703,078
2023-11-07 Omega Fund VI, L.P. 10% owner Purchase +454,545 $11.00 $5.0M 2,157,623
2023-11-07 Omega Fund VI, L.P. 10% owner Conversion · Series A convertible preferred stock −14,999,999 0
2023-11-07 Omega Fund VI, L.P. 10% owner Conversion · Series B convertible preferred stock −2,615,533 0

Page 1 of 1 · 5 trades